Cargando…

The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes

Aim: Channelrhodopsins (ChRs) are a large family of light-gated ion channels with distinct properties, which is of great importance in the selection of a ChR variant for a given application. However, data to guide such selection for cardiac optogenetic applications are lacking. Therefore, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ördög, Balázs, Teplenin, Alexander, De Coster, Tim, Bart, Cindy I., Dekker, Sven O., Zhang, Juan, Ypey, Dirk L., de Vries, Antoine A. F., Pijnappels, Daniël A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448166/
https://www.ncbi.nlm.nih.gov/pubmed/34539432
http://dx.doi.org/10.3389/fphys.2021.710020
_version_ 1784569178340982784
author Ördög, Balázs
Teplenin, Alexander
De Coster, Tim
Bart, Cindy I.
Dekker, Sven O.
Zhang, Juan
Ypey, Dirk L.
de Vries, Antoine A. F.
Pijnappels, Daniël A.
author_facet Ördög, Balázs
Teplenin, Alexander
De Coster, Tim
Bart, Cindy I.
Dekker, Sven O.
Zhang, Juan
Ypey, Dirk L.
de Vries, Antoine A. F.
Pijnappels, Daniël A.
author_sort Ördög, Balázs
collection PubMed
description Aim: Channelrhodopsins (ChRs) are a large family of light-gated ion channels with distinct properties, which is of great importance in the selection of a ChR variant for a given application. However, data to guide such selection for cardiac optogenetic applications are lacking. Therefore, we investigated the functioning of different ChR variants in normal and pathological hypertrophic cardiomyocytes subjected to various illumination protocols. Methods and Results: Isolated neonatal rat ventricular cardiomyocytes (NRVMs) were transduced with lentiviral vectors to express one of the following ChR variants: H134R, CatCh, ReaChR, or GtACR1. NRVMs were treated with phenylephrine (PE) to induce pathological hypertrophy (PE group) or left untreated [control (CTL) group]. In these groups, ChR currents displayed unique and significantly different properties for each ChR variant on activation by a single 1-s light pulse (1 mW/mm(2): 470, 565, or 617 nm). The concomitant membrane potential (V(m)) responses also showed a ChR variant-specific profile, with GtACR1 causing a slight increase in average V(m) during illumination (V(plateau): −38 mV) as compared with a V(plateau) > −20 mV for the other ChR variants. On repetitive activation at increasing frequencies (10-ms pulses at 1–10 Hz for 30 s), peak currents, which are important for cardiac pacing, decreased with increasing activation frequencies by 17–78% (p < 0.05), while plateau currents, which are critical for arrhythmia termination, decreased by 10–75% (p < 0.05), both in a variant-specific manner. In contrast, the corresponding V(plateau) remained largely stable. Importantly, current properties and V(m) responses were not statistically different between the PE and CTL groups, irrespective of the variant used (p > 0.05). Conclusion: Our data show that ChR variants function equally well in cell culture models of healthy and pathologically hypertrophic myocardium but show strong, variant-specific use-dependence. This use-dependent nature of ChR function should be taken into account during the design of cardiac optogenetic studies and the interpretation of the experimental findings thereof.
format Online
Article
Text
id pubmed-8448166
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84481662021-09-18 The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes Ördög, Balázs Teplenin, Alexander De Coster, Tim Bart, Cindy I. Dekker, Sven O. Zhang, Juan Ypey, Dirk L. de Vries, Antoine A. F. Pijnappels, Daniël A. Front Physiol Physiology Aim: Channelrhodopsins (ChRs) are a large family of light-gated ion channels with distinct properties, which is of great importance in the selection of a ChR variant for a given application. However, data to guide such selection for cardiac optogenetic applications are lacking. Therefore, we investigated the functioning of different ChR variants in normal and pathological hypertrophic cardiomyocytes subjected to various illumination protocols. Methods and Results: Isolated neonatal rat ventricular cardiomyocytes (NRVMs) were transduced with lentiviral vectors to express one of the following ChR variants: H134R, CatCh, ReaChR, or GtACR1. NRVMs were treated with phenylephrine (PE) to induce pathological hypertrophy (PE group) or left untreated [control (CTL) group]. In these groups, ChR currents displayed unique and significantly different properties for each ChR variant on activation by a single 1-s light pulse (1 mW/mm(2): 470, 565, or 617 nm). The concomitant membrane potential (V(m)) responses also showed a ChR variant-specific profile, with GtACR1 causing a slight increase in average V(m) during illumination (V(plateau): −38 mV) as compared with a V(plateau) > −20 mV for the other ChR variants. On repetitive activation at increasing frequencies (10-ms pulses at 1–10 Hz for 30 s), peak currents, which are important for cardiac pacing, decreased with increasing activation frequencies by 17–78% (p < 0.05), while plateau currents, which are critical for arrhythmia termination, decreased by 10–75% (p < 0.05), both in a variant-specific manner. In contrast, the corresponding V(plateau) remained largely stable. Importantly, current properties and V(m) responses were not statistically different between the PE and CTL groups, irrespective of the variant used (p > 0.05). Conclusion: Our data show that ChR variants function equally well in cell culture models of healthy and pathologically hypertrophic myocardium but show strong, variant-specific use-dependence. This use-dependent nature of ChR function should be taken into account during the design of cardiac optogenetic studies and the interpretation of the experimental findings thereof. Frontiers Media S.A. 2021-08-23 /pmc/articles/PMC8448166/ /pubmed/34539432 http://dx.doi.org/10.3389/fphys.2021.710020 Text en Copyright © 2021 Ördög, Teplenin, De Coster, Bart, Dekker, Zhang, Ypey, de Vries and Pijnappels. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Ördög, Balázs
Teplenin, Alexander
De Coster, Tim
Bart, Cindy I.
Dekker, Sven O.
Zhang, Juan
Ypey, Dirk L.
de Vries, Antoine A. F.
Pijnappels, Daniël A.
The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title_full The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title_fullStr The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title_full_unstemmed The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title_short The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes
title_sort effects of repetitive use and pathological remodeling on channelrhodopsin function in cardiomyocytes
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448166/
https://www.ncbi.nlm.nih.gov/pubmed/34539432
http://dx.doi.org/10.3389/fphys.2021.710020
work_keys_str_mv AT ordogbalazs theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT tepleninalexander theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT decostertim theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT bartcindyi theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT dekkersveno theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT zhangjuan theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT ypeydirkl theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT devriesantoineaf theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT pijnappelsdaniela theeffectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT ordogbalazs effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT tepleninalexander effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT decostertim effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT bartcindyi effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT dekkersveno effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT zhangjuan effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT ypeydirkl effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT devriesantoineaf effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes
AT pijnappelsdaniela effectsofrepetitiveuseandpathologicalremodelingonchannelrhodopsinfunctionincardiomyocytes